Connie L. Batlevi, MD, PhD, discusses the efficacy of tazemetostat in patients with follicular lymphoma and an EZH2 mutation.
Connie L. Batlevi, MD, PhD
Advertisement
Connie W. Batlevi (Lee), MD, PhD, is an oncologist in New York, NY, and is affiliated with Memorial Sloan Kettering Cancer Center.
Articles by Connie L. Batlevi, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
2
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
3
Beyond SC Daratumumab: Emerging Therapeutic Approaches for Smoldering Myeloma
4
FDA Approves Liso-Cel as First CAR T for Marginal Zone Lymphoma
5
